魯北化工(600727.SH):擬使用不超6億元自有資金進行委託理財
格隆匯3月24日丨魯北化工(600727.SH)公佈,公司於2022年3月24日分別召開第九屆董事會第二次會議、第九屆監事會第二次會議,審議通過了《關於2022年度使用自有資金進行委託理財的議案》,為提高暫時自有資金使用效率,在確保不影響公司正常經營,並有效控制風險的前提下,充分利用自有資金購買安全性高、流動性好、低風險的理財產品,以增加公司投資收益,擬在2022年度使用最高不超過6億元的自有資金進行委託理財,購買安全性高、流動性好、低風險、短期(不超過1年)的理財產品,在上述額度內,該類資金可以單筆或分筆進行單次或累計滾動購買不超過一年期的理財產品,財務部門在上述額度範圍內具體實施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.